
Peer-reviewed research, patent filings, and scientific communications documenting Regenevia’s contributions to epigenetic science and regenerative medicine.
Our research program is documented through a growing body of peer-reviewed publications, patent filings, and scientific communications. Below is a selection of key works that reflect the depth and direction of our scientific efforts.
Five patent applications protecting our core innovations in epigenetic rejuvenation and regenerative medicine.
US Patent Application
Autologous 3D Micro-Tissue Generation System
Innovative system for generating personalized autologous serums using advanced 3D micro-tissue technology for regenerative medicine.
US Patent Application
System of Aging Reversal in an Adult Human Being
Comprehensive system for reversing biological aging through controlled epigenetic reprogramming.
US Patent Application
Personalized Autologous Serum Production
Method for producing personalized serums from patient’s own epithelial cells with patented molecular cocktail.
US Patent Application
Biologically Active Autologous Fillers
Advanced method for producing biologically active fillers yielding rich extracellular matrix with collagen, elastin, and HA.
US Patent Application
Genesis7 Systemic Bioactive Serum
Groundbreaking method for preparing systemic autologous bioactive serum for deep rejuvenation via IV infusion.
By Dr. Giorgio Sergio Carlo Lynch
A comprehensive exploration of epigenetic rejuvenation science, information theory applied to biological systems, and the new frontiers of human longevity. Includes the full text of the first USPTO patent for human rejuvenation.
Research papers and preprints published on the Zenodo open-access repository.
Scientific presentations and posters at international conferences on epigenetics, regenerative medicine, and longevity research.
Internal research reports and white papers documenting experimental results, protocol development, and translational progress.
We welcome collaboration with academic institutions, research centers, and industry partners who share our commitment to rigorous, ethical science.
Contact Our Research TeamREGENEVIA BIO
Epigenetic Science & Cellular Reprogramming Research
Privacy Policy · Terms of Use · Disclaimer
© 2025 Regenevia Bio. All rights reserved. Part of the Lynch Group.
Peer-reviewed preprints and patent filings — Open Access on Zenodo (CERN)
Peer-reviewed preprints and patent filings — Open Access on Zenodo (CERN)
REGENEVIA BIO utilizza WordPress
Peer-reviewed preprints and patent filings — Open Access on Zenodo (CERN)